These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17173486

  • 1. Impact of statin copayments on adherence and medical care utilization and expenditures.
    Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA.
    Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486
    [Abstract] [Full Text] [Related]

  • 2. The effects of prescription drug copayments on statin adherence.
    Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S.
    Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440
    [Abstract] [Full Text] [Related]

  • 3. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
    Ye X, Gross CR, Schommer J, Cline R, St Peter WL.
    Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
    [Abstract] [Full Text] [Related]

  • 4. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
    Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ.
    Circulation; 2007 Apr 24; 115(16):2128-35. PubMed ID: 17420348
    [Abstract] [Full Text] [Related]

  • 5. The impact of reducing cardiovascular medication copayments on health spending and resource utilization.
    Choudhry NK, Fischer MA, Avorn JL, Lee JL, Schneeweiss S, Solomon DH, Berman C, Jan S, Lii J, Mahoney JJ, Shrank WH.
    J Am Coll Cardiol; 2012 Oct 30; 60(18):1817-24. PubMed ID: 23040581
    [Abstract] [Full Text] [Related]

  • 6. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL, Cox ER.
    Am J Manag Care; 2008 Dec 30; 14(12):813-8. PubMed ID: 19067498
    [Abstract] [Full Text] [Related]

  • 7. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R.
    Ann Pharmacother; 2011 Mar 30; 45(3):342-9. PubMed ID: 21325098
    [Abstract] [Full Text] [Related]

  • 8. Is there a relationship between early statin compliance and a reduction in healthcare utilization?
    Aubert RE, Yao J, Xia F, Garavaglia SB.
    Am J Manag Care; 2010 Jun 30; 16(6):459-66. PubMed ID: 20560689
    [Abstract] [Full Text] [Related]

  • 9. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA, Norman H, Weatherby LB, Walker AM.
    Pharmacotherapy; 2006 Aug 30; 26(8):1157-64. PubMed ID: 16863491
    [Abstract] [Full Text] [Related]

  • 10. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.
    Gibson TB, Jing Y, Kim E, Bagalman E, Wang S, Whitehead R, Tran QV, Doshi JA.
    Manag Care; 2010 Aug 30; 19(8):40-7. PubMed ID: 20822071
    [Abstract] [Full Text] [Related]

  • 11. Effect of statin adherence on cerebrovascular disease in primary prevention.
    Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.
    Am J Med; 2009 Jul 30; 122(7):647-55. PubMed ID: 19559167
    [Abstract] [Full Text] [Related]

  • 12. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 30; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 13. Factors related to adherence to statin therapy.
    McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, Steiner JF.
    Ann Pharmacother; 2007 Nov 30; 41(11):1805-11. PubMed ID: 17925498
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
    Foody JM, Joyce AT, Rudolph AE, Liu LZ, Benner JS.
    Clin Ther; 2008 Jan 30; 30(1):195-205. PubMed ID: 18343257
    [Abstract] [Full Text] [Related]

  • 15. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations.
    Pittman DG, Chen W, Bowlin SJ, Foody JM.
    Am J Cardiol; 2011 Jun 01; 107(11):1662-6. PubMed ID: 21439533
    [Abstract] [Full Text] [Related]

  • 16. Effect of tiered prescription copayments on the use of preferred brand medications.
    Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS.
    Med Care; 2003 Mar 01; 41(3):398-406. PubMed ID: 12618643
    [Abstract] [Full Text] [Related]

  • 17. Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome.
    Philipson TJ, Mozaffari E, Maclean JR.
    Am J Manag Care; 2010 Apr 01; 16(4):290-7. PubMed ID: 20394466
    [Abstract] [Full Text] [Related]

  • 18. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
    Chodick G, Shalev V, Gerber Y, Heymann AD, Silber H, Simah V, Kokia E.
    Clin Ther; 2008 Nov 01; 30(11):2167-79. PubMed ID: 19108805
    [Abstract] [Full Text] [Related]

  • 19. Pattern of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study.
    Helin-Salmivaara A, Lavikainen PT, Korhonen MJ, Halava H, Martikainen JE, Saastamoinen LK, Virta L, Klaukka T, Huupponen R.
    Am J Manag Care; 2010 Feb 01; 16(2):116-22. PubMed ID: 20148616
    [Abstract] [Full Text] [Related]

  • 20. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M, Biddle AK, Stearns SC.
    Clin Ther; 2008 Feb 01; 30 Spec No():1003-16. PubMed ID: 18640475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.